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INTRODUCTION
 Meningiomas are the most common primary 
extra-axial non-glial intracranial tumors, comprise 
approximately 14–20% of all intracranial tumors.1,2 
Meningiomas commonly occur on the brain 
surface and rarely in the brain ventricles. Mostly 
they are seen in middle aged patients showing 
female predilection with male:female ratio of 1:2.3 
Tumors less than 2.5cm are rarely symptomatic 
whereas, larger tumors show symptoms which 
worsen with time.4
 Most of meningiomas are typically benign, 
slow growing and curable by surgery depending 
on location.5 About 10% of meningiomas are 
atypical or malignant associated with higher 
morbidity and mortality. They may invade the 
adjacent bone and brain parenchyma so prone to 
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ABSTRACT
Objective: To determine the diagnostic accuracy of DWI in differentiating benign and malignant meningiomas 
keeping histopathology as gold standard.
Methods: This was a descriptive analytical study conducted at Radiology Department, DUHS/Dr. Ruth K. M. 
Pfau Civil Hospital Karachi, from August 2016 to March 2018.It included152 patients clinically suspected of 
meningioma on conventional neuroimaging. Imaging features of DWI were compared with histopathology 
findings. The diagnostic accuracy of DWI was calculated in terms of sensitivity, specificity, accuracy, PPV 
and NPV using histopathology as gold standard.
Results: There were 59 male and 93 female patients with mean age of 55.38±9.8 years. Mean duration of 
sign and symptoms was 5.67±2.57 months. Out of 152 patients, 117(77%) and 35(23%) were differentiated 
into benign and malignant meningiomas respectively by DWI while 135(88.82%) and17(11.18%) patients 
were diagnosed respectively on histopathology. The sensitivity, specificity, PPV, NPV and accuracy of DWI 
of 84.4%, 82.3%, 97.4%, 40%, and 84.2% respectively keeping histopathology as gold standard.
Conclusion: DWI features along with calculation of ADC values is a reliable non-invasive technique for 
differentiating benign and malignant meningiomas. However the low negative predictive value necessitates 
the use of histopathology.
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recur in 29% - 41% of patients.6 So it is important 
to distinguish them correctly for treatment 
planning, deciding the aggressiveness of surgical 
resection and the need of combined radiation 
therapy.2,7 Though some radiological features on 
conventional neuroimaging like intratumoral 
cystic change, hyperostosis of the adjacent skull, 
bony destruction, extracranial tumor extension 
through the skull base, arterial encasement, and 
peritumoral brain edema have been found to 
distinguish these two entities; no single feature 
has been found to be highly reliable.8
 Diffusion weighted imaging (DWI) is a non-
invasive technique, based on the measurement 
of water diffusion in tissues, which provides 
information about tissue microstructures, 
important in the grading of tumors before surgery.9 
Few previous studies have  found that the atypical/ 
malignant meningiomas tend to be markedly 
hyperintense on diffusion weighted images 
(DWI) and exhibit markedly decreased value on 
apparent diffusion coefficient (ADC) imaging when 
compared with normal brain parenchyma, while the 
benign meningiomas have a variable appearance on 
diffusion weighted images and tend to have higher 
ADC values compared with normal brain.6,9,10 
However these already conflicting results needs to 
be validated in our population, where tuberculomas 
are common confounders for the meningiomas 
and may give a similar appearance with caseous 
material simulating signals of calcification on 
screening MRI. So this study was conducted to 
compare diffusion-weighted imaging findings of 
different meningiomas by using apparent diffusion 
coefficient (ADC) values for predicting tumor grade 
into benign and malignant meningiomas.
METHODS
 It was a descriptive analytical study conducted 
at CT & MRI Centre, Dow University of Health 
Sciences/Dr. Ruth K. M. Pfau Civil Hospital 
Karachi, from August 2016 to March 2018. Inclusion 
criteria were patients of either gender between 20-
70 years of age, primarily suspected of meningioma 
on clinical features and conventional cross sectional 
imaging either on MRI or CT scan in last 12 weeks, 
and underwent DWI at the study centre. Patients 
who had claustrophobia, history of indwelling 
metallic implants and cardiac pacemakers, post-
operative or recurrent meningiomas were excluded 
from the study.
 Sample size was calculated by taking expected 
sensitivity 72.9% and specificity 73.1% of DWI9 with 
desired precision of 0.10, 35% prevalence11 and 95% 
confidence level. The total calculated sample size 
was 152. Written informed consent was obtained 
from each subject and permission was also obtained 
from The Institutional Review Board.
 Diffusion Weighted images (DWI) were obtained 
using a single-shot echo planar spin echo technique 
(TR/TE/NEX: 4200/140 ms/I) with diffusion 
sensitivities of b values = 0, 500 and 1000 s/mm2 on 
a 1.5-Tesla MR scanner (GE Health Care Signa H D). 
The diffusion gradients were applied sequentially 
in three orthogonal directions (X, Y and Z 
directions). The scanning parameters were 5 mm 
slice thickness, 1mm interslice gap, 240mm FOV 
and a matrix of 128 x 256 with 80s total acquisition 
time. Three types of images were obtained; 
orthogonal images, trace images and ADC maps. 
The ADC maps were calculated automatically by 
MRI software and included in the sequence. ADC 
values were measured in 10− 3mm2/s by keeping 
different regions of interest (ROI) in the lesion and 
contralateral region.
 Images were analyzed and reported as benign 
or malignant meningiomas according to DWI 
using ADC values and then compared with 
histopathological diagnosis obtained later after 
tumor resection at the Neurosurgery department of 
the same hospital. 
 Data collected was analyzed by SSPS program 
version 20. Mean and standard deviation were 
calculated for quantitative variables like age and 
duration since diagnosis on conventional MRI/CT 
scan.Frequency and percentages were calculated for 
qualitative variables like gender, diagnosis on DWI 
and histopathological diagnosis were calculated. 
The diagnostic accuracy of Diffusion weighted 
MRI for differentiating benign and malignant 
Meningiomas was calculated in terms of sensitivity, 
specificity, positive predictive values and negative 
predictive values keeping histopathology as gold 
standard. Post-stratification 2x2 table was generated 
to calculate these parameters.
RESULTS
 One hundred and fifty two patients were enrolled 
to determine the diagnostic accuracy of Diffusion 
Weighted MRI in differentiating benign and 
malignant meningiomas keeping histopathology 
as gold standard.There were 59 males and 93 
females, aged from 21 to 70 years with mean age 
of 55.38 ± 9.8 years. The mean duration of sign and 
symptoms of study subjects was 5.67 ± 2.57 months 
while the mean duration after primary diagnosis 
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of meningioma on conventional CT / MRI till 
differentiation on diffusion weighted MRI of study 
subjects was 4.7 ± 2.5 weeks. 
 Out of 152 patients, 117 patients (77%) showed 
benign meningiomas; while 35 patients (23%) 
showed malignant meningiomas on diffusion 
weighted MRI (DWI) using ADC values (Fig. 
1 and 2). While 135 (88.82%) were found to be 
benign meningiomas and 17 (11.18%) as malignant 
meningiomas on histopathology. Twelve patients 
out of 17 having malignant meningioma were seen 
in male patients.
 So 114 patients were correctly differentiated by 
DWI using ADC values as benign meningioma and 
14 patients as malignant/atypical meningiomas 
when compared with histopathology resulting 
in sensitivity of 84.4%, specificity of 82.3%, PPV 
of 97.4%, NPV of 40% and accuracy of 84.2% 
(Table-I). 
DISCUSSION
 Meningiomas are common but often an 
incidental finding on neuroimaging. The benign 
meningiomas are promptly diagnosed but their 
Diagnostic accuracy of DW-MRI in benign and malignant meningiomas
Fig.1: Axial T2WI, T1WI, DWI and ADC images show 
a benign suprasellar meningioma without diffusion 
restriction on DWI/ADC.
Fig.2: Axial T2WI, T1WI, DWI and ADC images reveal 
a malignant posterior parietal meningioma showing 
diffusion restriction on DWI/ADC and marked 
peritumoral edema.
Table-I: Diagnostic accuracy of DWI with Histopathology as 
Gold Standard to differentiate benign and Malignant Meningiomas (n= 152).
Benign ( n = 135 )
Histopathology
P-value
Malignant ( n = 17 ) Total
DWI/ADC
Benign ( n = 117 ) 114 3 117
P<0.001Malignant  ( n = 35 ) 21 14 35
TOTAL 135 17 152
Sensitivity Specificity PPV NPV Accuracy
84.4% 82.3% 97.4% 40% 84.2%
Chi square test was applied, P-Value ≤0.001 considered as significant.
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differentiation from atypical/malignant tumors 
by using conventional MRI is still quite difficult. 
Neuroimaging features like heterogeneous 
signals and enhancement, perilesional edema, 
and irregular cerebral surface are not unique and 
reliable to diagnose malignant meningiomason 
conventional MRI. For the surgical and treatment 
planning a diagnostic method is highly desirable for 
accurate distinction between benign and malignant 
meningiomas.12
 Diffusion weighted imaging (DWI) along with the 
calculation of apparent diffusion coefficient (ADC), 
is a reliable and non-invasive technique of choice 
for accurate assessment and in treatment planning 
of different types of brain tumors. It has more 
advantages in the distinction and differentiation of 
benign from malignant meningiomas on the basis 
of ADC values.12
 Several studies are available that characterize 
meningioma by DWI, however the provided data 
was inconsistent.6,10,13-15 Some did not identify any 
significant difference between the mean ADC ratios 
of benign and atypical/malignant tumors13 while 
some studies found that the mean ADC value of 
benign tumors was significant higher than the ADC 
value of atypical/malignant meningiomas.6,10,14,15 
So this study was done to assess the overall 
performance of the DWI in terms of sensitivity, 
specificity, positive predictive value (PPV), 
negative predictive value (NPV) and accuracy in 
our population.
 In this study, the mean age of patients 
was 55.38±9.8 years which is comparable to 
Kane AJ et al.16 and Ignjatovic J et al.17 that showed 
mean age of patients was 54 years and 53 years. In 
the current study, meningiomas particularly benign 
were found more frequent in females but malignant 
meningioma were more commonly observed in 
male, which is corroborating the reports from 
Samadi N et al.18 and Kane AJ et al.16
 The benign meningioma showed variable 
appearance like hypointense, isointense and 
slightly hyperintense on DWI and ADC maps 
with ADC values of more than 0.85×10-3mm2/sec 
while malignant/atypical meningiomas returned 
hyperintense signals on DWI and hypointense in 
ADC maps, with ADC values less than 0.85×10-
3mm2/sec. Similar signals were demonstrated by 
Khedr SA et al.2 and Liu Y et al.19 in their studies. 
Liu Y et al.19 also found that hyperintensity of lesion 
on DWI as the strongest independent predictor of 
high grade meningioma.
 This study showed 84.4% sensitivity of DWI 
which was comparable with the study done 
by Tantawy HI et al.20 (83.3%) but was higher 
than Suruv A et al.15 (72.9%) and less than 
Nagar VA et al.14 (96%). The specificity of DWI 
was 82.3% in this study which was comparable 
to the studies by Nagar VA et al.14 (82.6%) 
and Bano S et al.12 (83.2%) but higher than the 
study by Todua F et al.21 (80.0%) and Suruv A 
et al.15 (73.1%) in differentiating meningiomas. 
Our study showed higher positive predictive 
value than by Tantawy HI et al.20 (83.3%) and 
Nagar VA et al.14 (85.7%).
 Our study also showed overall better results 
except the negative predictive value than a 
study done by Surov A et al.9 who determined 
the sensitivity of 72.9%; specificity of 73.1%; 
accuracy of 73.0%; positive predictive value of 
33.3% and negative predictive value of 96.8%, 
respectively taking ADCmean value of less than 0.85 
× 10− 3 mm2s− 1 to differentiate between benign and 
atypical/malignant meningiomas.
 Most previous studies have showed variable 
negative predictive value ranging from 68.3% 
to 96.8% to distinguish benign and malignant 
meningiomas by DWI.9,12,15,20 While our study 
showed low negative predictive value of 40%, which 
may be either due to different study population, 
variation in age and gender of study population 
or small sample size of study population. Another 
reason may include the necrosis of malignancy that 
may be mistaken for cystic change of benign etiology 
on DWI alone. So despite good accuracy, sensitivity 
and specificity DWI MRI negative for malignancy 
still needs to be confirmed with histopathology.
Limitations in this study: It was small sample 
size and the study was confined to single centre. 
Another limitation was the low negative predictive 
value (NPV) in this study likely to be due to varying 
tumor morphology, which warrants further 
research on larger population.
CONCLUSION
 A DWI MRI scan has a high sensitivity, specificity 
and accuracy; but a negative scan suggesting benign 
disease has to be interpreted with caution due to 
low negative predictive value. Histopathology 
should not be omitted in such cases.
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